125 related articles for article (PubMed ID: 29729575)
1. Proteome analysis of the potential serum biomarkers for chronic benzene poisoning.
Zhang Z; Li P; Lin D; Wang D; Zhang Y
Environ Toxicol Pharmacol; 2018 Jun; 60():157-164. PubMed ID: 29729575
[TBL] [Abstract][Full Text] [Related]
2. Proteomics analysis identified serum biomarkers for occupational benzene exposure and chronic benzene poisoning.
Li P; Wu Y; Zhang Z; Lin D; Wang D; Huang X; Zhang Y
Medicine (Baltimore); 2019 Jun; 98(25):e16117. PubMed ID: 31232959
[TBL] [Abstract][Full Text] [Related]
3. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.
Kitamura Y; Usami R; Ichihara S; Kida H; Satoh M; Tomimoto H; Murata M; Oikawa S
Neurol Res; 2017 Mar; 39(3):231-238. PubMed ID: 28107809
[TBL] [Abstract][Full Text] [Related]
4. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
[TBL] [Abstract][Full Text] [Related]
5. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma].
Chen J; Wu W; Chen L; Ma X; Zhao Y; Zhou H; Yang R; Hu L
Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(28):2175-9. PubMed ID: 25331466
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of plasma biomarkers in uterine leiomyoma.
Lin CP; Chen YW; Liu WH; Chou HC; Chang YP; Lin ST; Li JM; Jian SF; Lee YR; Chan HL
Mol Biosyst; 2012 Apr; 8(4):1136-45. PubMed ID: 22193648
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of pancreatic cancer peripheral blood by comparative proteomics].
Chen J; Wu W; Tang HK; Zheng CS; Xia YL; Zhou HC; Yang RB; Chen LJ; Hu LW
Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):62-5. PubMed ID: 23578431
[TBL] [Abstract][Full Text] [Related]
9. Investigation of serum proteome alterations in human glioblastoma multiforme.
Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S
Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992
[TBL] [Abstract][Full Text] [Related]
10. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
[TBL] [Abstract][Full Text] [Related]
11. Two-Dimensional Differential Gel Electrophoresis to Identify Protein Biomarkers in Amniotic Fluid of Edwards Syndrome (Trisomy 18) Pregnancies.
Hsu TY; Lin H; Hung HN; Yang KD; Ou CY; Tsai CC; Cheng HH; Chung SH; Cheng BH; Wong YH; Chou AK; Hsiao CC
PLoS One; 2016; 11(1):e0145908. PubMed ID: 26752631
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential biomarkers of hepatotoxicity by plasma proteome analysis of arsenic-exposed carp Labeo rohita.
Banerjee S; Mahanty A; Mohanty S; Mazumder DG; Cash P; Mohanty BP
J Hazard Mater; 2017 Aug; 336():71-80. PubMed ID: 28475914
[TBL] [Abstract][Full Text] [Related]
13. New poteintial serum biomarkers in multiple sclerosis identified by proteomic strategies.
Amin B; Maurer A; Voelter W; Melms A; Kalbacher H
Curr Med Chem; 2014; 21(13):1544-56. PubMed ID: 24180278
[TBL] [Abstract][Full Text] [Related]
14. Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis.
Liu W; Liu B; Cai Q; Li J; Chen X; Zhu Z
Clin Chim Acta; 2012 Jul; 413(13-14):1098-106. PubMed ID: 22446497
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid A and clusterin as potential predictive biomarkers for severe hand, foot and mouth disease by 2D-DIGE proteomics analysis.
Liu J; Huang P; He Y; Hong WX; Ren X; Yang X; He Y; Wang W; Zhang R; Yang H; Zhao Z; Huang H; Chen L; Zhao D; Xian H; Yang F; Ma D; Yang L; Yin Y; Zhou L; Chen X; Cheng J
PLoS One; 2014; 9(9):e108816. PubMed ID: 25268271
[TBL] [Abstract][Full Text] [Related]
16. [Utilizing 2-DE and MALDI-TOF MS/MS to screen differentially expressed serum proteins of silicosis].
Zeng JW; Wang SX; Zhao XF; Wei MT; Tu ZG
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Mar; 25(3):136-41. PubMed ID: 17498342
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive plasma profiling for the characterization of graft-versus-host disease biomarkers.
De Bock M; Beguin Y; Leprince P; Willems E; Baron F; Deroyer C; Seidel L; Cavalier E; de Seny D; Malaise M; Gothot A; Merville MP; Fillet M
Talanta; 2014 Jul; 125():265-75. PubMed ID: 24840443
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
19. Plasma-based proteomic profiling identifies the distinct regulation of proteins in hyperplasia and endometrial cancer.
Akkour K; Alanazi IO; Alfadda AA; Masood A; Alhalal H; Joy SS; Bassi A; Alshehri E; Alwehaibi MA; Arafah M; Benabdelkamel H
BMC Cancer; 2024 Jun; 24(1):752. PubMed ID: 38902713
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of plasma proteins in diabetic retinopathy patients by two dimensional electrophoresis and MALDI-Tof-MS.
Gopalakrishnan V; Purushothaman P; Bhaskar A
J Diabetes Complications; 2015; 29(7):928-36. PubMed ID: 26129748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]